553 related articles for article (PubMed ID: 34526087)
21. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
22. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
Hurt W; Youngs J; Ball J; Edgeworth J; Hopkins P; Jenkins DR; Leaver S; Mazzella A; Molloy SF; Schelenz S; Wise MP; White PL; Yusuff H; Wyncoll D; Bicanic T
Thorax; 2023 Dec; 79(1):75-82. PubMed ID: 37657925
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
[TBL] [Abstract][Full Text] [Related]
24. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
[TBL] [Abstract][Full Text] [Related]
25. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
26. Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis.
Kariyawasam RM; Dingle TC; Kula BE; Vandermeer B; Sligl WI; Schwartz IS
Clin Microbiol Infect; 2022 Jul; 28(7):920-927. PubMed ID: 35150878
[TBL] [Abstract][Full Text] [Related]
27. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
Chong WH; Saha BK; Neu KP
Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
[TBL] [Abstract][Full Text] [Related]
28. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
[TBL] [Abstract][Full Text] [Related]
29. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
[TBL] [Abstract][Full Text] [Related]
30. Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study.
Melchers M; van Zanten ARH; Heusinkveld M; Leeuwis JW; Schellaars R; Lammers HJW; Kreemer FJ; Haas PJ; Verweij PE; van Bree SHW
Crit Care Explor; 2022 May; 4(5):e0696. PubMed ID: 35558738
[TBL] [Abstract][Full Text] [Related]
31. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
Salmanton-García J; Sprute R; Stemler J; Bartoletti M; Dupont D; Valerio M; Garcia-Vidal C; Falces-Romero I; Machado M; de la Villa S; Schroeder M; Hoyo I; Hanses F; Ferreira-Paim K; Giacobbe DR; Meis JF; Gangneux JP; Rodríguez-Guardado A; Antinori S; Sal E; Malaj X; Seidel D; Cornely OA; Koehler P;
Emerg Infect Dis; 2021; 27(4):1077-1086. PubMed ID: 33539721
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit.
Iacovelli A; Oliva A; Mirabelli FM; Giannone S; Laguardia M; Morviducci M; Nicolardi ML; Repaci E; Sanzari MT; Leanza C; Raponi G; Mastroianni C; Palange P
BMC Infect Dis; 2024 Apr; 24(1):392. PubMed ID: 38605300
[TBL] [Abstract][Full Text] [Related]
33. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
[TBL] [Abstract][Full Text] [Related]
34. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
Huang JR; Shen HC; Sun CY; Chen WC; Chen YM; Feng JY; Yang KY
J Formos Med Assoc; 2022 Dec; 121(12):2617-2625. PubMed ID: 35953342
[TBL] [Abstract][Full Text] [Related]
35. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
[TBL] [Abstract][Full Text] [Related]
36. COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020-March 2021.
Sivasubramanian G; Ghanem H; Maison-Fomotar M; Jain R; Libke R
J Fungi (Basel); 2021 Nov; 7(11):. PubMed ID: 34829235
[TBL] [Abstract][Full Text] [Related]
37. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography.
Baratella E; Roman-Pognuz E; Zerbato V; Minelli P; Cavallaro MFM; Cova MA; Luzzati R; Lucangelo U; Sanson G; Friso F; Bussani R; Pinamonti M; Busetti M; Salton F; Confalonieri M; Ruaro B; Di Bella S
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1607-1612. PubMed ID: 34994174
[TBL] [Abstract][Full Text] [Related]
38. Association between Pulmonary Aspergillosis and
Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
[TBL] [Abstract][Full Text] [Related]
39. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis.
Hawes AM; Permpalung N
Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
